Breaking Barriers: How 9M Insulin Pens Will Transform Diabetes Care in South Africa
Loading player...
This week on The Social Impact Show, Tabeeng Lepeng (Public Affairs Director, Novo Nordisk SA) reveals a historic milestone: South Africa’s public sector will now access life-saving modern insulin pens—closing the gap between private and public healthcare.
🔑 Key Moments:
07:12 – *"Why 60% of diabetics struggle with adherence—and how pre-mixed pens change the game."*
15:30 – The shocking truth: Only 9M South Africans have medical aid, leaving millions reliant on state care.
22:45 – How Novo Nordisk partnered with government to fast-track insulin onto the Essential Medicines List (EML).
💡 Why It Matters:
Diabetes is now the #2 cause of death in SA—but this tender ensures equitable access to cutting-edge treatment for 4M+ patients.
🚀 Take Action:
Join the conversation: #HealthForAll #DiabetesAwareness
🔑 Key Moments:
07:12 – *"Why 60% of diabetics struggle with adherence—and how pre-mixed pens change the game."*
15:30 – The shocking truth: Only 9M South Africans have medical aid, leaving millions reliant on state care.
22:45 – How Novo Nordisk partnered with government to fast-track insulin onto the Essential Medicines List (EML).
💡 Why It Matters:
Diabetes is now the #2 cause of death in SA—but this tender ensures equitable access to cutting-edge treatment for 4M+ patients.
🚀 Take Action:
Join the conversation: #HealthForAll #DiabetesAwareness